Publications

• The Adverse Event Landscape of Stem Cell Transplant: Evidence for AGVHD Driving Early Transplant Associated Toxicities.
  Transplant Cell Ther Volume: 31 Page(s): 109.e1 - 109.e13
  02/01/2025 Authors: Takahashi T; Watkins B; Bratrude B; Neuberg D; Hebert K; Betz K; Yu A; Choi SW; Davis J; Duncan C
• Abatacept for acute graft-versus-host disease prophylaxis after unrelated donor hematopoietic cell transplantation.
  Blood Volume: 144 Page(s): 1834 - 1845
  10/24/2024 Authors: Kean LS; Burns LJ; Kou TD; Kapikian R; Lozenski K; Langston A; Horan JT; Watkins B; Qayed M; Bratrude B
• Age, GVHD prophylaxis, and timing matter in thrombotic microangiopathy after haematopoietic cell transplantation-Asecondary CIBMTR analysis.
  Br J Haematol Volume: 205 Page(s): 243 - 255
  07/01/2024 Authors: Schoettler ML; Westbrook A; Watkins B; Stenger E; Qayed M; Chonat S; Williams KM
• Toward a more systematic understanding of water insecurity coping strategies: insights from 11 global sites.
  BMJ Glob Health Volume: 9
  05/31/2024 Authors: Collins SM; Mock N; Chaparro MP; Rose D; Watkins B; Wutich A; Young SL; HWISE Research Coordination Network
• Overlap chronic GVHD is associated with adverse survival outcomes compared to classic chronic GVHD.
  Bone Marrow Transplant Volume: 59 Page(s): 680 - 687
  05/01/2024 Authors: Gorfinkel L; Raghunandan S; Watkins B; Hebert K; Neuberg DS; Bratrude B; Betz K; Yu A; Choi SW; Davis J
• D-dimer and sinusoidal obstructive syndrome-novel poor prognostic features of thrombotic microangiopathy in children after hematopoietic cellular therapy in a single institution prospective cohort study.
  Am J Hematol Volume: 99 Page(s): 370 - 379
  03/01/2024 Authors: Schoettler ML; French K; Harris A; Bryson E; Deeb L; Hudson Z; Obordo J; Chandrakasan S; Parikh S; Watkins B
• Compassionate Use Narsoplimab for Severe Refractory Transplantation-Associated Thrombotic Microangiopathy in Children.
  Transplant Cell Ther Volume: 30 Page(s): 336.e1 - 336.e8
  03/01/2024 Authors: Schoettler ML; Patel S; Bryson E; Deeb L; Watkins B; Qayed M; Chandrakasan S; Fitch T; Silvis K; Jones J
• Novel approaches to acute graft-versus-host disease prevention.
  Hematology Am Soc Hematol Educ Program Volume: 2023 Page(s): 155 - 163
  12/08/2023 Authors: Watkins B; Qayed M
• Short-Course Empiric Antibiotics in Children Undergoing Allogeneic Hematopoietic Cell Transplantation.
  Transplant Cell Ther Volume: 29 Page(s): 778.e1 - 778.e6
  12/01/2023 Authors: Patel PA; Teherani MF; Xiang Y; Bernardo V; Chandrakasan S; Goggin KP; Haight A; Horwitz E; Liang WH; Parikh SH
• Abatacept for graft versus host disease prophylaxis in patients 60 years and older receiving mismatched unrelated donor transplantation for hematologic malignancies.
  Bone Marrow Transplant Volume: 58 Page(s): 1264 - 1266
  11/01/2023 Authors: Raghunandan S; Qayed M; Watkins BK; Graiser M; Gorfinkel L; Westbrook A; Gillespie S; Bratrude B; Petrovic A; Suessmuth Y
• Abatacept for the prevention of graft versus host disease in pediatric patients receiving 7/8 HLA-mismatched unrelated transplant for hematologic malignancies: a real-world analysis.
  Bone Marrow Transplant Volume: 58 Page(s): 1260 - 1263
  11/01/2023 Authors: Raghunandan S; Gorfinkel L; Bratrude B; Suessmuth Y; Hebert K; Neuberg D; Williams KM; Schoettler ML; Langston AA; Kean LS
• Severe refractory hemorrhagic cystitis after hematopoietic cell transplantation responds to recombinant human keratinocyte growth factor-Case report and review of the literature.
  Pediatr Blood Cancer Volume: 70 Page(s): e30606
  10/01/2023 Authors: Hughes C; Harris A; Watkins B; Qayed M; Parikh S; Horwitz E; Stenger E; Williams KM; Schoettler ML
• Higher abatacept exposure after transplant decreases acute GVHD risk without increasing adverse events.
  Blood Volume: 142 Page(s): 700 - 710
  08/24/2023 Authors: Takahashi T; Al-Kofahi M; Jaber M; Bratrude B; Betz K; Suessmuth Y; Yu A; Neuberg DS; Choi SW; Davis J
• Abatacept for the prevention of GVHD in patients receiving mismatched unrelated transplants: a real-world analysis.
  Blood Adv Volume: 7 Page(s): 4395 - 4399
  08/22/2023 Authors: Raghunandan S; Gorfinkel L; Graiser M; Bratrude B; Suessmuth Y; Gillespie S; Westbrook AL; Williams KM; Schoettler ML; Kean LS
• A retrospective review on the histopathological pattern of childhood malignant solid tumors in Ethiopia.
  Pediatr Blood Cancer Volume: 70 Page(s): e30424
  08/01/2023 Authors: Ayele RH; Yimer YG; Bekuretsion Y; Muhe LM; Patel SA; Cunningham SA; Hailu D; Watkins B
• IMPACT OF TRANSPLANT ASSOCIATED THROMBOTIC MICROANGIOPATHY AND ACUTE GRAFT VERSUS HOST DISEASE ON SURVIVAL IN CHILDREN AFTER ALLOGENEIC HEMATOPOIETIC CELLULAR TRANSPLANTATION
  Volume: 70 Page(s): S217 - S217
  06/01/2023 Authors: Schoettler M; Harris A; Bryson E; Deeb L; Watkins B; Haight A; Parikh S; Chandrakasan S; Stenger E; Liang W
• STEROID-ASSOCIATED ADVERSE EVENTS ARE DOSE-DEPENDENT FOLLOWING HEMATOPOIETIC CELL TRANSPLANTATION
  Volume: 70 Page(s): S213 - S213
  06/01/2023 Authors: Lisac R; Raghunandan S; Gillespie S; Liu K; Qayed M; Williams K; Watkins B
• Abatacept GVHD prophylaxis in unrelated hematopoietic cell transplantation for pediatric bone marrow failure.
  Blood Adv Volume: 7 Page(s): 2196 - 2205
  05/23/2023 Authors: Stenger EO; Watkins B; Rogowski K; Chiang K-Y; Haight A; Leung K; Qayed M; Raghunandan S; Suessmuth Y; Kean L
• Sickle cell disease is a risk factor for transplant-associated thrombotic microangiopathy in children.
  Blood Adv Volume: 7 Page(s): 1784 - 1795
  05/09/2023 Authors: Schoettler M; Stenger E; Spencer K; Lutterman D; Rumbika S; Jones J; Haight A; Parikh S; Qayed M; Watkins B
• BCMA CAR-T induces complete and durable remission in refractory plasmablastic lymphoma.
  J Immunother Cancer Volume: 11
  05/01/2023 Authors: Raghunandan S; Pauly M; Blum WG; Qayed M; Dhodapkar MV; Elkhalifa M; Watkins B; Schoettler M; Horwitz E; Parikh S
• Diffuse alveolar hemorrhage after hematopoietic cell transplantation- response to treatments and risk factors for mortality.
  Front Oncol Volume: 13 Page(s): 1232621
  01/01/2023 Authors: Schoettler ML; Dandoy CE; Harris A; Chan M; Tarquinio KM; Jodele S; Qayed M; Watkins B; Kamat P; Petrillo T
• Pulmonary Manifestations and Vascular Changes in Pediatric Transplantation-Associated Thrombotic Microangiopathy.
  Transplant Cell Ther Volume: 29 Page(s): 45.e1 - 45.e8
  01/01/2023 Authors: Schoettler ML; Saldana BD; Berkenkamp L; Chonat S; Watkins B; Rotz SJ; Simons D; Graf E; Rossi C; Cheng J
• Compassionate use narsoplimab to treat transplant associated thrombotic microangiopathy in a pediatric patient with multi-organ failure
  Volume: 57 Page(s): 350 - 350
  11/01/2022 Authors: Schoettler M; Bryson E; Deeb L; Qayed M; Watkins B; Chandrakasan S; Chonat S; Williams K
• Overlap chronic graft-versus-host disease (GvHD) is associated aith an adverse prognosis: secondary analysis of the ABA2 trial
  Volume: 57 Page(s): 41 - 41
  11/01/2022 Authors: Gorfinkel L; Raghunandan S; Langston A; Westbrook A; Gillespie S; Bratrude B; Betz K; Choi SW; Davis J; Duncan C
• Case Report: The First Case Report of Visceral Leishmaniasis in Cambodia.
  Am J Trop Med Hyg Volume: 107 Page(s): 336 - 338
  08/17/2022 Authors: Lyvannak S; Sreynich K; Heng S; Thyl M; Chandna A; Chanpheaktra N; Pises N; Farrilend P; Jarzembowski J; Leventaki V
• ABATACEPT FOR THE PREVENTION OF GVHD IN PEDIATRIC PATIENTS RECEIVING 7/8 HLA-MISMATCHED TRANSPLANT
  Volume: 69
  06/01/2022 Authors: Raghunandan S; Gorfinkel L; Bratrude B; Betz K; Suessmuth Y; Gillespie S; Westbrook A; Williams K; Schoettler M; Langston A
• BCMA CAR-T AFTER ALLOGENEIC HCT INDUCES REMISSION IN REFRACTORY PLASMABLASTIC LYMPHOMA
  Volume: 69
  06/01/2022 Authors: Raghunandan S; Pauly M; Blum W; Qayed M; Dhodapkar M; Elkhalifa M; Watkins B; Schoettler M; Horwitz E; Parikh S
• Blinatumomab induces complete response in refractory PTLD after hematopoietic cell transplantation.
  Blood Adv Volume: 6 Page(s): 3058 - 3061
  05/24/2022 Authors: Janardan S; Horwitz E; Watkins B; Williams K; Chandrakasan S; Qayed M; Parikh S; Arnold S; Keller F; Alazraki A
• Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation.
  Blood Adv Volume: 6 Page(s): 746 - 749
  02/08/2022 Authors: Qayed M; Watkins B; Gillespie S; Bratrude B; Betz K; Choi SW; Davis J; Duncan C; Giller R; Grimley M
• Controversies and expectations for the prevention of GVHD: A biological and clinical perspective.
  Front Immunol Volume: 13 Page(s): 1057694
  01/01/2022 Authors: Watkins B; Williams KM
• Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD.
  J Clin Oncol Volume: 39 Page(s): 1865 - 1877
  06/10/2021 Authors: Watkins B; Qayed M; McCracken C; Bratrude B; Betz K; Suessmuth Y; Yu A; Sinclair S; Furlan S; Bosinger S
• USE OF HYPOMETHYLATING AGENTS IN RELAPSED/REFRACTORY PEDIATRIC ACUTE MYELOID LEUKEMIA
  Volume: 68 Page(s): S52 - S53
  06/01/2021 Authors: Sabnis H; Raikar S; Bennett A; MacDonald K; Watkins B; Woods W; Keller F
• Spatiotemporal single-cell profiling reveals that invasive and tissue-resident memory donor CD8+ T cells drive gastrointestinal acute graft-versus-host disease.
  Sci Transl Med Volume: 13
  01/13/2021 Authors: Tkachev V; Kaminski J; Potter EL; Furlan SN; Yu A; Hunt DJ; McGuckin C; Zheng H; Colonna L; Gerdemann U
• Potent Interaction between CMV Reactivation and Gvhd: Immunologic Evidence for Blunting of CMV-Driven Immune Reconstitution in the Setting of Gvhd
  Volume: 136
  11/05/2020 Authors: Suessmuth Y; Betz K; Yu A; Bratrude B; Watkins B; Qayed M; Horan JT; Kean L; Langston A
• Predicting Immune Pathology after Hematopoietic Stem Cell Transplant with Transcriptomics: Naive CD4 T Cell Expansion at Day 100 Predicts Patients with De Novo Chronic Gvhd
  Volume: 136
  11/05/2020 Authors: Watkins B; Kaminski J; Qayed M; Betz K; Suessmuth Y; Bratrude B; Yu A; Tkachev V; Pellegrini K; Bosinger S
• Potent interaction between CMV reactivation and GVHD: Immunologic evidence for the blunting of CMV-driven immune reconstitution in the setting of GVHD in transplant patients
  Volume: 204
  05/01/2020 Authors: Suessmuth Y; Betz K; Yu A; Bratrude B; Watkins B; Qayed M; Horan J; Kean LS; Langston A
• A phase I study of sirolimus in combination with metronomic therapy (CHOAnome) in children with recurrent or refractory solid and brain tumors.
  Volume: 67 Page(s): e28134
  04/01/2020 Authors: Qayed M; Cash T; Tighiouart M; MacDonald TJ; Goldsmith KC; Tanos R; Kean L; Watkins B; Suessmuth Y; Wetmore C
• Transcriptomic Analysis of CD4+T Cell Dysfunction during Gvhd: Evidence for Profound Reprograming of T Cell Signaling during Acute Gvhd That Is Controlled during CD28:CD80/86 Costimulation Blockade with Abatacept
  Volume: 134
  11/13/2019 Authors: Watkins B; Suessmuth Y; Betz K; Yu A; Bratrude B; Qayed M; Pellegrini K; Bosinger S; Langston A; Horan JT
• T cell costimulation blockade with abatacept for acute graft-versus-host disease prevention in matched and mismatched unrelated donor transplantation: Results of the first phase 2 trial
  Volume: 54 Page(s): 81 - 82
  07/01/2019 Authors: Qayed M; Watkins B; Bratrude B; Betz K; Rhodes J; Sinclair S; Suessmuth Y; Yu A; Dean C; Cribbin K
• CD28 blockade controls T cell activation to prevent graft-versus-host disease in primates.
  J Clin Invest Volume: 128 Page(s): 3991 - 4007
  08/31/2018 Authors: Watkins BK; Tkachev V; Furlan SN; Hunt DJ; Betz K; Yu A; Brown M; Poirier N; Zheng HB; Taraseviciute A
• PANETH CELL COUNTS INDEPENDENTLY PREDICT ACUTE GASTROINTESTINAL GVHD STAGE AND RESPONSE TO THERAPY
  Volume: 65
  06/01/2018 Authors: Leblanc Z; Shehata B; Gillespie S; Farris A; Watkins B; Horan J; Qayed M
• Early blood stream infection following allogeneic hematopoietic stem cell transplantation is a risk factor for acute grade III-IV GVHD in children and adolescents.
  Pediatr Blood Cancer Volume: 65
  02/01/2018 Authors: Sano H; Hilinski JA; Qayed M; Applegate K; Newton JG; Watkins B; Chiang K-Y; Horan J
• Combined OX40L and mTOR blockade controls effector T cell activation while preserving Treg reconstitution after transplant.
  Sci Transl Med Volume: 9
  09/20/2017 Authors: Tkachev V; Furlan SN; Watkins B; Hunt DJ; Zheng HB; Panoskaltsis-Mortari A; Betz K; Brown M; Schell JB; Zeleski K
• Recipient and donor age impact the risk of developing chronic GvHD in children after allogeneic hematopoietic transplant.
  Bone Marrow Transplant Volume: 52 Page(s): 625 - 626
  04/01/2017 Authors: Watkins BK; Horan J; Storer B; Martin PJ; Carpenter PA; Flowers MED
• A Novel Therapeutic Strategy to Control Conventional T-Cells While Supporting Treg Reconstitution Post-Transplant: Long-Term GVHD-Free Survival by Combining OX40L Blockade with Rapamycin
  Volume: 23 Page(s): S20 - S20
  03/01/2017 Authors: Tkachev V; Furlan SN; Watkins BK; Zheng HB; Hunt D; Panoskaltsis-Mortari A; Betz K; Brown M; Zeleski K; Yu A
• The Knife's Edge of Tolerance: Inducing Stable Multilineage Mixed Chimerism but With a Significant Risk of CMV Reactivation and Disease in Rhesus Macaques.
  Am J Transplant Volume: 17 Page(s): 657 - 670
  03/01/2017 Authors: Zheng HB; Watkins B; Tkachev V; Yu S; Tran D; Furlan S; Zeleski K; Singh K; Hamby K; Hotchkiss C
• Striking Clinical, Molecular and Immunological Outcomes in Non-Human Primate Hematopoietic Stem Cell Transplantation Using a Novel OX40L Blockade Agent, KY1005, Combined with Rapamycin
  Volume: 128
  12/02/2016 Authors: Tkachev V; Furlan SN; Watkins B; Zheng B; Hunt D; Panoskaltsis-Mortari A; Betz K; Brown M; Zeleski K; Yu A
• Preclinical Testing of Antihuman CD28 Fab' Antibody in a Novel Nonhuman Primate Small Animal Rodent Model of Xenogenic Graft-Versus-Host Disease.
  Transplantation Volume: 100 Page(s): 2630 - 2639
  12/01/2016 Authors: Hippen KL; Watkins B; Tkachev V; Lemire AM; Lehnen C; Riddle MJ; Singh K; Panoskaltsis-Mortari A; Vanhove B; Tolar J
• Systems analysis uncovers inflammatory Th/Tc17-driven modules during acute GVHD in monkey and human T cells.
  Blood Volume: 128 Page(s): 2568 - 2579
  11/24/2016 Authors: Furlan SN; Watkins B; Tkachev V; Cooley S; Panoskaltsis-Mortari A; Betz K; Brown M; Hunt DJ; Schell JB; Zeleski K
• Preclinical testing of anti-human CD28 Fab' antibody in a novel nonhuman primate (NHP) small animal rodent model of xenogenic graft-versus-host disease (GVHD).
  Transplantation
  09/08/2016 Authors: Hippen KL; Watkins B; Tkachev V; Lemire AM; Lehnen C; Riddle MJ; Singh K; Panoskaltsis-Mortari A; Vanhove B; Tolar J
• Biological role of T Memory Stem Cells as a Cellular Reservoir for Graft-versus-Host Disease
  Volume: 196
  05/01/2016 Authors: Tkachev V; Furlan SN; Watkins BK; Panoskaltsis-Mortari A; Blazar BR; Kean LS
• T Stem Cell Memory Dynamics during Acute Graft-Versus-Host Disease
  Volume: 126
  12/03/2015 Authors: Tkachev V; Furlan SN; Watkins B; Panoskaltsis-Mortari A; Blazar BR; Kean L
• Transcriptome analysis of GVHD reveals aurora kinase A as a targetable pathway for disease prevention.
  Sci Transl Med Volume: 7 Page(s): 315ra191
  11/25/2015 Authors: Furlan SN; Watkins B; Tkachev V; Flynn R; Cooley S; Ramakrishnan S; Singh K; Giver C; Hamby K; Stempora L
• CMV reactivation drives posttransplant T-cell reconstitution and results in defects in the underlying TCR repertoire.
  Blood Volume: 125 Page(s): 3835 - 3850
  06/18/2015 Authors: Suessmuth Y; Mukherjee R; Watkins B; Koura DT; Finstermeier K; Desmarais C; Stempora L; Horan JT; Langston A; Qayed M
• T-Cell Transcriptome Analysis Reveals the Mechanisms Controlling Synergy Between Costimulation Blockade and mTOR Inhibition during GVHD Prevention
  Volume: 21 Page(s): S329 - S330
  02/01/2015 Authors: Furlan SN; Watkins BK; Mortari A; Blazar BR; Kean LS
• Exhaustive TCR Deep Sequencing Reveals That CMV Reactivation Fundamentally Resets Immune Reconstitution after Transplant and Results in Significant Deficits in the Effector Memory TCR Repertoire
  Volume: 21 Page(s): S69 - S70
  02/01/2015 Authors: Suessmuth Y; Koura D; Finstermeier K; Desmarais C; Horan J; Langston A; Qayed M; Khoury HJ; Watkins BK; Robins H
• Defining the Primate T Cell Transcriptome during GvHD: New Data Implicating Sonic Hedgehog and Aurora Kinase Pathways in GvHD Pathogenesis and Prevention
  Volume: 21 Page(s): S56 - S56
  02/01/2015 Authors: Furlan SN; Watkins BK; Mortari A; Blazar BR; Giver C; Waller EK; Kean LS
• Defining the Primate T Cell Transcriptome during Graft Versus Host Disease: New Data Implicating the Hedgehog and Aurora Kinase Pathways in Pathogenesis and Prevention
  Volume: 124
  12/06/2014 Authors: Furlan SN; Watkins B; Flynn RP; Ramakrishnan S; Singh K; Giver CR; Hanby K; Stempora L; Garrett AP; Ziegler CGK
• Preventing Primate GvHD Using a Novel Antagonistic Anti-CD28 Antibody Plus Rapamycin: Downregulation of CD8 Activation and Preservation of the Naive Cell Phenotype Predicts GvHD-Free Survival
  Volume: 124
  12/06/2014 Authors: Watkins B; Garrett AP; Chen J; Furlan SN; Hamby K; Vanhove B; Kean LS
• T-Cell Transcriptome Analysis Reveals the Mechanisms Controlling Synergy Between Costimulation Blockade and mTOR Inhibition during Graft Versus Host Disease Prevention
  Volume: 124
  12/06/2014 Authors: Furlan SN; Watkins B; Hanby K; Garrett AP; Panoskaltsis-Mortari A; Blazar BR; Kean LS
• TARGETING SIV RESERVOIRS THROUGH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANT IN RHESUS MACAQUES
  JOURNAL OF MEDICAL PRIMATOLOGY Volume: 43 Page(s): 380 - 380
  10/01/2014 Authors: Mavigner M; Watkins B; Lawson B; Chahroudi A; Kean L; Silvestri G
• Persistence of virus reservoirs in ART-treated SHIV-infected rhesus macaques after autologous hematopoietic stem cell transplant.
  PLoS Pathog Volume: 10 Page(s): e1004406
  09/01/2014 Authors: Mavigner M; Watkins B; Lawson B; Lee ST; Chahroudi A; Kean L; Silvestri G
• CD8-predominant T-cell CNS infiltration accompanies GVHD in primates and is improved with immunoprophylaxis.
  Blood Volume: 123 Page(s): 1967 - 1969
  03/20/2014 Authors: Kaliyaperumal S; Watkins B; Sharma P; Furlan S; Ramakrishnan S; Giver C; Garcia A; Courtney C; Knight H; Strobert E
• Preventing Primate Gvhd Using a Novel Antagonistic Anti-CD28 Antibody Plus Rapamycin: Downregulation of CD8 Proliferation Predicts Gvhd-Free Survival
  Volume: 20 Page(s): S56 - S56
  02/01/2014 Authors: Watkins BK; Poirier N; Mary C; Blancho G; Singh K; Garrett A; Hamby K; Deane T; Blazar BR; Vanhove B
• CD8-Predominant T Cell Meningitis Accompanies Gvhd in Primates and Is Prevented with Immunoprophylaxis
  Volume: 20 Page(s): S270 - S272
  02/01/2014 Authors: Kaliyaperumal S; Sharma P; Watkins BK; Furlan SN; Ramakrishnan S; Giver C; Garcia A; Courtney C; Hamby K; Garrett A
• Comparison of automated red cell exchange transfusion and simple transfusion for the treatment of children with sickle cell disease acute chest syndrome.
  Pediatr Blood Cancer Volume: 60 Page(s): 1952 - 1956
  12/01/2013 Authors: Saylors RL; Watkins B; Saccente S; Tang X
• COMPARISON OF AUTOMATED RED CELL EXCHANGE TRANSFUSION AND SIMPLE TRANSFUSION FOR THE TREATMENT OF CHILDREN WITH SICKLE CELL DISEASE ACUTE CHEST SYNDROME
  Volume: 60 Page(s): S17 - S17
  06/01/2013 Authors: Watkins B; Saylors R; Saccente S; Tang X
• Synergistic Control of Acute GvHD: Effectively Down-Regulating T Cell Proliferation and Cytotoxicity with Combined mTOR Inhibition and CD28:CD80/86 Costimulation Blockade
  Volume: 19 Page(s): S139 - S139
  02/01/2013 Authors: Kozyr N; Ramakrishnan S; Polnett A; Hamby K; Tiwari D; Watkins B; Deane T; Stempora L; Elder E; Esiashvili N
• Comparison of Erythrocytapheresis and Simple Transfusion for the Treatment of Children with Sickle Cell Disease Acute Chest Syndrome
  Volume: 120
  11/16/2012 Authors: Watkins B; Saylors RL; Saccente S; Tang X
• CLINICAL VARIABLES AND ACUTE PHASE REACTANTS AT INITIAL HOSPITALIZATION AS PREDICTORS OF ADMISSION TO INTENSIVE CARE UNIT (ICU) AMONG FEBRILE NEUTROPENIC CHILDREN
  Volume: 37 Page(s): A344 - A344
  12/01/2009 Authors: Mian A; Prodhan P; Bhutta A; Watkins B
• A TWO YEAR RETROSPECTIVE REVIEW OF THE PRESENTATION OF ANTERIOR MEDIASTINAL MASSES AND THE CONSEQUENCES OF DELAY IN THEIR DIAGNOSIS
  Volume: 57 Page(s): 379 - 379
  01/01/2009 Authors: Watkins B; Mian A; Siddiqui S